If this intermediate is part of the API process, where API - Drug substance is not yet completed, then as per yellow highlighted, earlier attached file says it does not require listing.
If this intermediate is part of the drug product process, where Finished product is not yet formed, but it contains the API, then it needs to be listed.
It is still unclear that what kind of intermediate you are dealing with. But above is best of my understanding.
------------------------------
Gaurang Bhavsar, MS, RAC
Scientist-II, R&D and RA
Sunrise Pharmaceutical, Inc.
Rahway, NJ 07065
USA
------------------------------
Original Message:
Sent: 09-Nov-2017 21:49
From: Anonymous Member
Subject: Drug Substance Intermediate- Establishment Registration
This message was posted by a user wishing to remain anonymous
"unfinished drugs requiring further processing....." what do you call this? This require drug listing so there seems to be a conflict!!
Original Message:
Sent: 09-Nov-2017 14:16
From: Gaurang Bhavsar
Subject: Drug Substance Intermediate- Establishment Registration
Please see the attachment.
The "Intermediate" is highlighted in yellow for your ready reference.
------------------------------
Gaurang Bhavsar, MS, RAC
Scientist-II, R&D and RA
Sunrise Pharmaceutical, Inc.
Rahway, NJ 07065
USA
Original Message:
Sent: 08-Nov-2017 08:49
From: Sabrina Dessources
Subject: Drug Substance Intermediate- Establishment Registration
Good morning everyone,
Do you know of any requirements/regulations that state that Drug Substance Intermediate Manufacturers need to register their establishment with the FDA? The manufacturer is located outside of the US and we have recently received a question as part of a CRL asking for the manufacturer's FEI number. The establishment registration sections on FDA's website and in the CFR (207) are specific to drug substance/product; not intermediate.
Thanks,
Sabrina
@207.17 Who must register?
(a) Unless exempt under section 510(g) of the Federal Food, Drug, and Cosmetic Act or this part, all manufacturers, repackers, relabelers, and salvagers must register each domestic establishment that manufactures, repacks, relabels, or salvages a drug, or an animal feed bearing or containing a new animal drug, and each foreign establishment that manufactures, repacks, relabels, or salvages a drug, or an animal feed bearing or containing a new animal drug, that is imported or offered for import into the United States. When operations are conducted at more than one establishment and common ownership and control among all the establishments exists, the parent, subsidiary, or affiliate company may submit registration information for all establishments.